Gambogic acid activates AMP-activated protein kinase in mammalian cells

Biochemical and Biophysical Research Communications

Volumn 424, Issue 1, 2012, Pages 100-104

  Zhao, Baobing ^a   Shen, Huili ^a   Zhang, Lianru ^a   Shen, Yuemao ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

AMPK; Gambogic acid; Reactive oxygen species

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANTIOXIDANT; GAMBOGIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; REACTIVE OXYGEN METABOLITE; THIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME KINETICS; ENZYME PHOSPHORYLATION; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; MICE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; XANTHONES;

MAMMALIA;

EID: 84864093464     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.078     Document Type: Article

References (27)

1. Steinberg G.R., Kemp B.E. AMPK in Health and Disease. Physiol. Rev. 2009, 89:1025-1078.
2. Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009, 9:407-416.
3. Fogarty S., Hardie D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 2010, 1804:581-591.
4. Luo Z., Zang M., Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 2010, 6:457-470.
5. Vakana E., Altman J.K., Platanias L.C. Targeting AMPK in the treatment of malignancies. J. Cell. Biochem. 2012, 113:404-409.
6. Lu G.B., Yang X.X., Huang Q.S. Isolation and structure of neo-gambogic acid from Gamboge (Garcinia hanburryi). Yao Xue Xue Bao 1984, 19:636-639.
7. X. Wang, W. Chen, Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis, Anticancer Agents Med. Chem. (2012), http://dx.doi.org/ACAMC-EPUB-20120217-002. (Epub ahead of print).
8. Palempalli U.D., Gandhi U., Kalantari P., Vunta H., Arner R.J., Narayan V., Ravindran A., Prabhu K.S. Gambogic acid covalently modifies IkappaB kinase-beta subunit to mediate suppression of lipopolysaccharide-induced activation of NF-kappaB in macrophages. Biochem. J. 2009, 419:401-409.
9. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
10. Wang J., Zhao B., Zhang W., Wu X., Wang R., Huang Y., Chen D., Park K., Weimer B.C., Shen Y. Mycoepoxydiene, a fungal polyketide, induces cell cycle arrest at the G2/M phase and apoptosis in HeLa cells. Bioorg. Med. Chem. Lett. 2010, 20:7054-7058.
11. Xiao B., Sanders M.J., Underwood E., Heath R., Mayer F.V., Carmena D., Jing C., Walker P.A., Eccleston J.F., Haire L.F., Saiu P., Howell S.A., Aasland R., Martin S.R., Carling D., Gamblin S.J. Structure of mammalian AMPK and its regulation by ADP. Nature 2011, 472:230-233.
12. Nosenko Y., Kyrychenko A., Thummel R.P., Waluk J., Brutschy B., Herbich J. Fluorescence quenching in cyclic hydrogen-bonded complexes of 1H-pyrrolo[3,2-h]quinoline with methanol: cluster size effect. Phys. Chem. Chem. Phys. 2007, 9:3276-3285.
13. Abdiche Y., Malashock D., Pinkerton A., Pons J. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. Anal. Biochem. 2008, 377:209-217.
14. Hardie D.G. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 2007, 47:185-210.
15. Choi H.C., Song P., Xie Z., Wu Y., Xu J., Zhang M., Dong Y., Wang S., Lau K., Zou M.H. Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo. J. Biol. Chem. 2008, 283:20186-20197.
16. Zou M.H., Kirkpatrick S.S., Davis B.J., Nelson J.S., Wiles W.G.t., Schlattner U., Neumann D., Brownlee M., Freeman M.B., Goldman M.H. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J. Biol. Chem. 2004, 279:43940-43951.
17. Choi S.L., Kim S.J., Lee K.T., Kim J., Mu J., Birnbaum M.J., Soo Kim S., Ha J. The regulation of AMP-activated protein kinase by H(2)O(2). Biochem. Biophys. Res. Commun. 2001, 287:92-97.
18. Han Y., Wang Q., Song P., Zhu Y., Zou M.H. Redox regulation of the AMP-activated protein kinase. PLoS ONE 2010, 5:e15420.
19. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174.
20. Hardie D.G., Hawley S.A., Scott J.W. AMP-activated protein kinase-development of the energy sensor concept. J. Physiol. 2006, 574:7-15.
21. Carling D., Mayer F.V., Sanders M.J., Gamblin S.J. AMP-activated protein kinase: nature's energy sensor. Nat. Chem. Biol. 2011, 7:512-518.
22. Sanders M.J., Ali Z.S., Hegarty B.D., Heath R., Snowden M.A., Carling D. Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J. Biol. Chem. 2007, 282:32539-32548.
23. Pang T., Zhang Z.S., Gu M., Qiu B.Y., Yu L.F., Cao P.R., Shao W., Su M.B., Li J.Y., Nan F.J., Li J. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells. J. Biol. Chem. 2008, 283:16051-16060.
24. Fryer L.G., Parbu-Patel A., Carling D. Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4-imidazolecarboxamide riboside. FEBS Lett. 2002, 531:189-192.
25. Handa N., Takagi T., Saijo S., Kishishita S., Takaya D., Toyama M., Terada T., Shirouzu M., Suzuki A., Lee S., Yamauchi T., Okada-Iwabu M., Iwabu M., Kadowaki T., Minokoshi Y., Yokoyama S. Structural basis for compound C inhibition of the human AMP-activated protein kinase alpha2 subunit kinase domain. Acta Crystallogr. D Biol. Crystallogr. 2011, 67:480-487.
26. Yuwen Z.Q.C. Michael reaction acceptor molecules in chemical biology. Progress in Chemistry 2007, 19:1972-1976.
27. Powers J.C., Asgian J.L., Ekici O.D., James K.E. Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem. Rev. 2002, 102:4639-4750.